Best Lawyers in Massachusetts, United States for Mergers and Acquisitions Law

Mark Burnett, a partner in the firm's Corporate, Private Equity, M&A/Corporate Governance and Technology Companies groups, focuses primarily on business, corporate and securities law matters, mergers and acquisitions, buyouts, and corporate finance and venture capital transactions. His clients include public and private companies in a range of industries (including software, Internet services, telecommunications services, healthcare services and water purification), venture capital and pr...

John Egan, a partner and co-chair of the firm’s Technology practice, focuses on corporate securities, venture capital, growth equity and technology enterprises. Mr. Egan's practice involves early and late-stage venture financings, growth equity and leveraged recapitalizations, IPOs, mergers and acquisitions, joint ventures, strategic licensing and the general representation of public and private emerging growth companies. Mr. Egan works with clients in industries ranging from enterprise...

A co-leader of the firm's Mergers & Acquisitions Practice, Mary-Laura Greely has extensive experience as a transactional lawyer in mergers and acquisitions involving private and public companies, private equity, venture capital, and general corporate representation. She advises companies on strategic acquisitions and dispositions of companies, assets and divisions, significant debt and equity financings, management buy-outs, corporate governance and succession planning, employment, intell...

David Parke’s practice is focused on general corporate and business matters, including mergers and acquisitions and other transactional work. His practice includes helping businesses and other organizations, including nonprofit organizations, and their owners or managers, with contractual, organizational, commercial, trade and any other matters that arise in the normal course of operations. This includes drafting and negotiating all types of agreements and helping with all aspects of va...

Graham Robinson focuses his practice on mergers, acquisitions and other transactions in the pharmaceutical, medical device and technology industries in the U.S. and internationally. He also regularly represents both private equity funds and hedge funds on a wide range of matters. Mr. Robinson’s health care clients have included, among others, Alnara Pharmaceuticals, Alpharma Pharmaceuticals, Bayer, Dendreon Corporation, PerkinElmer Inc., Prism Pharmaceuticals, Savient Pharmaceuticals, T...

Lew is the director of Sullivan's Corporate Department in Boston. His practice is focused on a number of transactional areas. He regularly represents public and private companies in equity and debt financings, joint ventures, domestic and international mergers and acquisitions, and general corporate matters. Lew also represents financial institutions in secured and unsecured credit facilities. His clients consist of major financial institutions, private equity groups, family-owned businesses,...

Since joining Nixon Peabody almost 20 years ago, Phil has had the pleasure of advising investors, middle market private companies, large public companies, entrepreneurs and C-level executives in many different kinds of corporate transactions, all over North America, Europe, Asia and Africa. Phil was born in Southern Africa and finished his secondary education in the United States. His love of family, travel, outdoor adventure and community permeates everything he does. Phil has been described...

Yasin Akbari is an associate in the firm's internationally recognized Life Sciences group. Her practice covers a diverse range of complex transactions in the life sciences and technology industries, with a focus on mergers and acquisitions, royalty-based financings and other strategic investments, and capital markets transactions. She also acts as a day-to-day advisor to public and private companies, providing guidance on corporate governance, SEC reporting, and stock exchange compliance. Yas...

Benjamin J. Dionne is a corporate attorney in the Boston office of Kirkland & Ellis LLP, where his practice focuses on representing private equity sponsors and their portfolio companies, as well as other alternative asset managers, in a variety of complex corporate and transactional matters, including mergers and acquisitions, leveraged buyouts, growth equity and minority investments, joint ventures, corporate reorganizations and general corporate matters.

Kristin Gerber is a Partner in the firm's Business Law Department and a member of its nationally recognized Technology and Life Sciences groups. Ms. Gerber represents public and private emerging growth technology and healthcare companies, as well as venture capital funds and private equity and strategic acquirers focusing on software, hardware, biotechnology, pharmaceuticals and other technology-driven companies. She has experience advising companies through every stage of the corporate life ...

Craig Harasimowicz is a corporate attorney in Holland & Knight's Charlotte office. Mr. Harasimowicz represents private equity and venture capital firms, independent sponsors, search funds, strategic acquirers and companies in evaluating, structuring and negotiating mergers and acquisitions (M&A) and investment transactions, including leveraged buyouts, growth equity investments, mergers, stock and asset acquisitions and sales, as well as divestitures and recapitalizations. In addition...

Payson Lyman is a corporate partner in the Boston office of Kirkland & Ellis LLP, where his practice focuses on representing private equity sponsors in complex domestic and cross-border business transactions, including mergers and acquisitions, leveraged buyouts, and general corporate matters.

Daniel W. Vaczy is a partner in the Corporate Practice Group of Kirkland & Ellis LLP. Daniel represents Firm clients in complex corporate and transactional matters including mergers and acquisitions, leveraged buyouts, growth equity and minority investments, joint ventures, corporate reorganizations and general corporate matters relating to the portfolio companies of private equity clients.